Performance analysis of ProMIS Neurosciences (PMN)
Annual Return
Over the past 3 years, PMN has had an average annual return of -49.11%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, PMN has had an average annual return of +30.53%, outperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, PMN has had an average annual return of +15.74%, outperforming the benchmark SPY, which returned +14.95% annual.
Since Jul 17, 2007, PMN has had an average annual return of -4.17%, underperforming the benchmark SPY, which returned +10.61% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +120.84% | -71.19% | -17.58% | -73.50% | +3,844.58% | +32.68% | -36.18% | -34.67% | +16.97% | +66.67% | +179.93% | -74.86% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||
| -56.20% | -15.76% | +48.03% | -37.19% | -22.85% | +20.40% | -62.40% | -10.70% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +107.44% | +66.03% | -45.98% | -13.07% | -2.09% | +21.75% | +14.54% | +120.84% | |||||
| 2025 | -4.05% | -21.93% | -2.04% | -10.87% | -16.11% | -6.98% | +59.41% | -29.98% | -21.28% | -2.36% | -34.84% | +0.95% | -71.19% |
| 2024 | +73.91% | +4.50% | -8.61% | +4.87% | -8.04% | -18.57% | -4.34% | -4.79% | -8.51% | +1.60% | -25.99% | +0.84% | -17.58% |
| 2023 | +19.58% | -1.16% | -7.80% | +45.45% | -28.91% | -20.67% | -26.03% | -31.71% | +1.04% | -11.63% | -33.14% | -1.71% | -73.50% |
| 2022 | -4.31% | -5.02% | +0.14% | -10.15% | -0.30% | +13.75% | +5,849.14% | -7.74% | +9.47% | -4.57% | -3.08% | -23.46% | +3,844.58% |
| 2021 | -0.33% | +25.74% | +62.19% | -15.76% | +22.42% | -3.04% | -7.48% | +2.61% | -10.08% | +3.20% | -27.28% | +1.88% | +32.68% |
| 2020 | +30.87% | -11.47% | -40.23% | +44.43% | +7.72% | +14.33% | -7.96% | -4.51% | -23.60% | -16.02% | -20.72% | +15.91% | -36.18% |
| 2019 | -4.50% | +26.32% | -4.18% | -17.38% | -0% | -0% | +0% | -21.04% | +19.96% | -5.50% | -11.79% | -13.37% | -34.67% |
| 2018 | +194.02% | -35.99% | +12.49% | -13.89% | -9.70% | +7.16% | -13.32% | -7.71% | +0% | -12.48% | -19.03% | +16.97% | +16.97% |
| 2017 | +33.47% | +2.79% | -21.39% | +90.89% | +9.48% | -8.66% | -4.77% | -14.97% | +17.61% | -0% | -14.97% | +0% | +66.67% |
Drawdown analysis of ProMIS Neurosciences (PMN)
The maximum drawdown for the PMN was -98.80%, occurring on Mar 26, 2015. Recovery took 1823 trading sessions.
The current PMN drawdown is -93.48%.
Since Jul 17, 2007 PMN has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.80% | Jul 31, 2007 | 1919 | Mar 26, 2015 | 1823 | Jul 1, 2022 | 3742 |
| -97.08% | Jul 8, 2022 | 852 | Nov 28, 2025 | Ongoing | Ongoing | Ongoing |
| -9.29% | Jul 1, 2022 | 2 | Jul 6, 2022 | 2 | Jul 8, 2022 | 4 |
| -7.75% | Jul 17, 2007 | 2 | Jul 19, 2007 | 1 | Jul 20, 2007 | 3 |